MELALERT-PM Trademark

Trademark Overview

On Friday, July 19, 2019, a trademark application was filed for MELALERT-PM with the United States Patent and Trademark Office. The USPTO has given the MELALERT-PM trademark a serial number of 88524266. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 27, 2023. The MELALERT-PM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treatment of sleep and circadian rhythm disorders and conditions
melalert-pm

General Information

Serial Number88524266
Word MarkMELALERT-PM
Filing DateFriday, July 19, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 27, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 26, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations for treatment of sleep and circadian rhythm disorders and conditions

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 29, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNOT AVAILABLE
Party Type20 - Owner at Publication
Legal Entity Type01 - Individual
AddressMilwaukie, OR 97267
Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressMilwaukie, OR 97267

Trademark Events

Event DateEvent Description
Monday, February 27, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 27, 2023ABANDONMENT - NO USE STATEMENT FILED
Thursday, July 21, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 20, 2022SOU EXTENSION 5 GRANTED
Monday, July 18, 2022SOU EXTENSION 5 FILED
Monday, July 18, 2022SOU TEAS EXTENSION RECEIVED
Thursday, January 27, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 26, 2022SOU EXTENSION 4 GRANTED
Wednesday, January 19, 2022SOU EXTENSION 4 FILED
Wednesday, January 19, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, July 20, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 19, 2021SOU EXTENSION 3 GRANTED
Friday, July 16, 2021SOU EXTENSION 3 FILED
Friday, July 16, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, February 2, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 1, 2021SOU EXTENSION 2 GRANTED
Monday, January 18, 2021SOU EXTENSION 2 FILED
Monday, February 1, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, January 18, 2021SOU TEAS EXTENSION RECEIVED
Saturday, June 20, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 18, 2020SOU EXTENSION 1 GRANTED
Thursday, June 18, 2020SOU EXTENSION 1 FILED
Thursday, June 18, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, January 21, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 26, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 26, 2019PUBLISHED FOR OPPOSITION
Wednesday, November 6, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, October 17, 2019ASSIGNED TO LIE
Wednesday, October 9, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 9, 2019EXAMINER'S AMENDMENT ENTERED
Wednesday, October 9, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, October 9, 2019EXAMINERS AMENDMENT E-MAILED
Wednesday, October 9, 2019EXAMINERS AMENDMENT -WRITTEN
Tuesday, October 8, 2019ASSIGNED TO EXAMINER
Monday, July 29, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 23, 2019NEW APPLICATION ENTERED

Related Keywords

melalert rhythm disorders conditions circadian sleep preparations treatment pharmaceutical